AI assistant
Fagron N.V. — Capital/Financing Update 2017
Jul 3, 2017
3949_iss_2017-07-03_f78c9d53-8561-4c0d-878e-fc9f076e0d60.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Fagron announces that the bond loan of € 225 million will be redeemed in full today. The bond loan, which was listed on Euronext Brussels under ISIN code BE0002180462, was issued on 2 July 2012 at a fixed annual gross interest rate of 4.75% and with a maturity of 5 years. The last trading day for the bond loan, which consisted of 225,000 bonds with nominal value of € 1,000 per bond, was 28 June 2017. The bond was delisted on 29 June 2017.
In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.
For more information: Constantijn van Rietschoten Chief Communications Officer Tel. +31 6 53 69 15 85 [email protected]
Fagron profile
Fagron is a leading global company active in pharmaceutical compounding and focused on delivering tailored pharmaceutical care to hospitals, pharmacies, clinics and patients in 32 countries around the world.
The Belgian company Fagron NV is located in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR'. The operational activities of Fagron are driven by the Dutch company Fagron BV. The head office of Fagron BV is located in Rotterdam.